Skip to main content
. 2023 Oct 19;21:5186–5200. doi: 10.1016/j.csbj.2023.10.038

Table 3.

Predicted potential drug combinations.

Drug 1 Drug 2 Overlapped proteins
1 Belinostat Vorinostat HDAC1, HDAC2, HDAC3
2 Belinostat Panobinostat HDAC1, HDAC2, HDAC4, HDAC7, HDAC3
3 Belinostat Romidepsin HDAC1, HDAC2, HDAC4
4 Vorinostat Panobinostat HDAC1, HDAC2, HDAC3
5 Zinc Zinc chloride HDAC1, TP53, HDAC4, GAPDHS, KRT9
6 Zinc Copper KRT10, KRT2, KRT1, KRT9
7 Zinc Zinc sulfate HDAC1, TP53, HDAC4, GAPDHS
8 Zinc Zinc acetate HDAC1, KRT1, TP53, KRT2, KRT16, HDAC4, KRT14, HRNR, JUP, GAPDHS, KRT10, KRT9
9 Zinc chloride Zinc acetate HDAC1, TP53, HDAC4, GAPDHS
10 Zinc chloride Zinc sulfate HDAC1, TP53, HDAC4, GAPDHS
11 Copper Zinc acetate KRT10, KRT2, KRT1, KRT9
12 Panobinostat Romidepsin HDAC1, HDAC2, HDAC4
13 Zinc sulfate Zinc acetate HDAC1, TP53,HDAC4, GAPDHS